J&J Unit's Catheter Tying Policy Hurt Rival, Antitrust Jury Told

Innovative Health's CEO told a California federal jury considering its antitrust claims Wednesday that Johnson & Johnson unit Biosense Webster enforced a policy to cut off support to hospitals that didn't...

Already a subscriber? Click here to view full article